Renovos Biologics Limited

Renovos Biologics is a high-potential biotech venture with verified FDA Breakthrough Device Designation and strategic backing from Biocomposites. While the submission contained obviously false user claims ('most people have used my product') and poor data quality, the underlying technology (RENOVITE® nanoclay) solves a genuine medical problem (spinal fusion failure) with significant clinical utility. The score reflects the high value of the technology and regulatory progress, heavily penalized by the submission's lack of credible user data.